Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate after traumatic brain injury
ACTRN12613001219774Phase 2Recruiting
- Sponsor
- Australian Alzheimer's Research Foundation
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing Testosterone undecanoate with Placebo (2 arms). Primary endpoints: Cognitive and behavioral outcomes and Alzheimer's disease and neuroinflammation biomarkers. Started Feb 2014; status: recruiting.
02
Drugs
TSX-011
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12613001219774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001219774.